ICU Medical officer plans $1.1M stock sale

ICU Medical, Inc. (ICUI) officer Brian Michael Bonnell filed a notice under Rule 144 to sell common stock.

Rhea-AI Filing Summary

ICU Medical, Inc. (ICUI) officer Brian Michael Bonnell filed a notice under Rule 144 to sell common stock. The filing lists up to 6,381 shares of ICUI common stock to be sold through Morgan Stanley Smith Barney, with an aggregate market value of $1,116,675.00 and an approximate sale date of September 1, 2026. The shares derive from restricted stock and performance share awards granted between 2022 and 2024. The notice also reports that Bonnell sold 9,307 shares of ICUI common stock during the past three months for total proceeds of $1,608,142.82.

Key Figures

Shares to be sold under Rule 144: 6,381 shares of Common Stock Aggregate market value of planned sale: $1,116,675.00 Shares sold in past 3 months: 9,307 shares of Common Stock +5 more

8 metrics

Shares to be sold under Rule 144 6,381 shares of Common Stock Planned sale through Morgan Stanley Smith Barney; approximate sale date 09/01/2026

Aggregate market value of planned sale $1,116,675.00 Value of 6,381 ICUI common shares to be sold under Rule 144

Shares sold in past 3 months 9,307 shares of Common Stock Sold on 08/31/2026 by Brian Bonnell

Proceeds from past 3 months sales $1,608,142.82 Consideration for 9,307 ICUI shares sold on 08/31/2026

Restricted Stock grant 2022 1,046 shares Restricted Stock acquired 03/08/2022 from issuer

Restricted Stock grant 2023 1,046 shares Restricted Stock acquired 03/08/2023 from issuer

Restricted Stock grant 2024 998 shares Restricted Stock acquired 03/08/2024 from issuer

Performance Shares grant 2024 3,291 shares Performance Shares acquired 03/08/2024 from issuer

Key Terms

Rule 144, Restricted Stock, Performance Shares, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 03/08/2022 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Performance Shares financial

"Common | 03/08/2024 | Performance Shares | Issuer"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

aggregate market value financial

"| 6381 | 1116675.00 | 25007038 | 09/01/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing mean for ICU Medical (ICUI)?

The filing states that officer Brian Michael Bonnell plans to sell up to 6,381 shares of ICU Medical common stock under Rule 144, with an aggregate market value of $1,116,675.00 and an approximate sale date of September 1, 2026.

How many ICU Medical (ICUI) shares are covered by this Rule 144 notice?

The notice covers up to 6,381 shares of ICU Medical, Inc. common stock, with an aggregate market value stated as $1,116,675.00, to be sold through Morgan Stanley Smith Barney Executive Financial Services.

What prior ICU Medical (ICUI) sales did Brian Bonnell report in this Form 144?

The filing reports that 9,307 shares of ICU Medical common stock were sold on August 31, 2026 for total consideration of $1,608,142.82 during the past three months.

What types of equity awards underlie the ICU Medical (ICUI) shares in this Form 144?

The shares relate to Restricted Stock and Performance Shares granted by ICU Medical on March 8, 2022, March 8, 2023, and March 8, 2024, with individual award amounts of 1,046, 1,046, 998, and 3,291 shares.

Through which broker are the ICU Medical (ICUI) shares expected to be sold?

The shares are expected to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, New York, as listed in the Rule 144 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 04:08 PM Accepted by SEC EDGAR 09/01/2026 - 04:07 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001804831
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ICU MEDICAL, INC.
SEC File Number	001-34634
Address of Issuer	951 Calle Amanecer San Clemente CALIFORNIA 92673
Phone	(949) 366-2183
Name of Person for Whose Account the Securities are To Be Sold	BRIAN BONNELL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6381	1116675.00	25007038	09/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/08/2022	Restricted Stock	Issuer			1046	03/08/2022	Not Applicable
Common	03/08/2023	Restricted Stock	Issuer			1046	03/08/2023	Not Applicable
Common	03/08/2024	Restricted Stock	Issuer			998	03/08/2024	Not Applicable
Common	03/08/2024	Performance Shares	Issuer			3291	03/08/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRIAN BONNELL 951 Calle Amanecer San Clemente CA 92673	Common	08/31/2026	9307	1608142.82

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Brian Michael Bonnell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)